BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Pirogov Russian National Research Medical University
Moscú, RusiaPublications in collaboration with researchers from Pirogov Russian National Research Medical University (1)
2023
-
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
Blood, Vol. 141, Núm. 2, pp. 156-167